MetaCap

Rapid Micro Biosystems (RPID) vs Seer (SEER)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Seer (SEER) has outperformed Rapid Micro Biosystems (RPID) over the past year, losing 31.0% versus a loss of 82.4%. Over five years, SEER leads with a -94.1% price change compared with -94.4% for RPID. Seer is the larger company by market cap ($75.9 million vs $37.4 million), about 2.0 times the size, while Rapid Micro Biosystems is growing revenue faster (+19.7% vs +17.0%).

Rapid Micro Biosystems converts more of its revenue into profit, with a net margin of -140.3% versus -444.0%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

RPID-82.37%SEER-30.96%
+23%-33%-90%
Nov 21, 20251 yearNov 20, 2026
RPID-95.40%SEER-94.62%
+5%-48%-101%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

RPID versus SEER key metrics
MetricRPIDSEER
Share price$0.735$1.36
Market cap$37.37M$75.91M
1-day change-0.04%-1.81%
YTD return-74.66%-25.68%
1-year return-82.37%-30.96%
5-year return-94.41%-94.05%
EPS (TTM)$-1.06$-1.14
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$33.59M$16.58M
Revenue growth (YoY)+19.74%+16.99%
Net income (latest FY)$-47.12M$-73.60M
Gross margin—51.06%
Operating margin-141.10%-470.45%
Net margin-140.30%-443.96%
52-week high$4.94$2.38
52-week low$0.58$1.33
Distance from 52-week high-85.12%-42.74%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+682.31%+194.12%
Average volume577.05K216.28K
Shares outstanding46.34M55.81M
Employees171124
SectorIndustrialsIndustrials
IndustryBiotechnology: Laboratory Analytical InstrumentsBiotechnology: Laboratory Analytical Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Seer is about 2.0 times larger than Rapid Micro Biosystems by market value ($75.91M vs $37.37M).
  • SEER has outperformed RPID by 51.4 percentage points over the past year.
  • Rapid Micro Biosystems is more profitable, keeping -140.3 cents of every revenue dollar as net income versus -444.0 cents for Seer.

About Rapid Micro Biosystems

RPID stock →

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.

Industrials · Biotechnology: Laboratory Analytical Instruments · 171 employees

About Seer

SEER stock →

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.

Industrials · Biotechnology: Laboratory Analytical Instruments · 124 employees

RPID vs SEER FAQ

Which is bigger, Rapid Micro Biosystems or Seer?

Seer (SEER) is larger, with a market capitalization of $75.91M compared with $37.37M for Rapid Micro Biosystems (RPID).

Which stock has performed better over the past year, RPID or SEER?

SEER returned -30.96% over the past 12 months, compared with -82.37% for RPID (price return, excluding dividends). Past performance does not predict future results.

Are Rapid Micro Biosystems and Seer in the same industry?

Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.

More comparisons